Contracted portfolio revenue and NOI run rate
Company: Core Scientific
The claim, verbatim
Contracted capacity is expected to generate average annual recurring GAAP revenue of $1.8B and $1.6B of annual NOI, with over 50% of cash flows backed by investment-grade credit.
Source (primary)
Third Quarter Fiscal Year 2026 Earnings Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “Average annual recurring GAAP revenue of $1.8B generates $1.6B of annual NOI, with over 50% of cash flows backed by investment-grade credit”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Third Quarter Fiscal Year 2026 Earnings Presentation
Quote: “Average annual recurring GAAP revenue of $1.8B generates $1.6B of annual NOI, with over 50% of cash flows backed by investment-grade credit”